V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220019378 | 220007321 | 1.69 | 124.2 | Curative (C) | 2017-10-11 | 2017-10-25 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | N | 220028203 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019379 | 220021881 | 0 | 85 | Curative (C) | 2013-03-11 | 2013-06-08 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220028207 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019380 | 220007325 | 0 | 127 | null | 2017-04-09 | 2017-04-30 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220028231 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019381 | 220014038 | 0 | 81.6 | Curative (C) | 2013-05-13 | 2013-06-09 | AML18 PILOT TRIAL | N | N | 220028246 | PILOT TRIAL |
| 220019382 | 220007330 | 1.77 | 0 | Disease modification (D) | 2018-07-06 | 2018-09-26 | Rituximab | 02 | N | 220028254 | RITUXIMAB |
| 220019383 | 220007335 | 1.7 | 65.2 | Disease modification (D) | 2018-01-13 | 2018-01-14 | Dasatinib | 2 | N | 220028284 | DASATINIB |
| 220019384 | 220014044 | 1.75 | 64.1 | Curative (C) | 2017-07-05 | 2018-03-25 | Dasatinib | N | N | 220028292 | DASATINIB |
| 220019385 | 220014047 | 1.84 | 86.1 | Disease modification (D) | 2017-05-17 | 2017-05-18 | Rituximab | N | N | 220028304 | RITUXIMAB |
| 220019386 | 220007343 | 1.77 | 110 | Curative (C) | 2015-01-19 | 2015-01-19 | AML 18 TRIAL | N | N | 220028308 | AML18 TRIAL |
| 220019387 | 220007346 | 1.55 | 51.5 | Curative (C) | 2013-07-19 | 2013-08-29 | AML18 PILOT TRIAL | N | N | 220028341 | PILOT TRIAL |
| 220019388 | 220007349 | 1.6 | 67.2 | Adjuvant (A) | 2015-06-15 | 2015-08-07 | AML18 PILOT TRIAL | Y | N | 220028355 | PILOT TRIAL |
| 220019389 | 220017660 | 1.8 | 72.8 | Curative (C) | 2015-06-04 | 2015-07-09 | AML 18 TRIAL | N | N | 220028370 | AML18 TRIAL |
| 220019390 | 220007357 | 1.6 | 0 | Curative (C) | 2018-01-24 | 2018-01-24 | Dasatinib | N | N | 220028384 | DASATINIB |
| 220019391 | 220017661 | null | 100 | Palliative (P) | 2018-10-02 | 2018-12-15 | AML 18 TRIAL | N | N | 220028388 | AML18 TRIAL |
| 220019392 | 220007359 | 0 | 63.9 | Disease modification (D) | 2015-11-24 | 2015-11-24 | AML18 PILOT TRIAL | Y | null | 220028395 | PILOT TRIAL |
| 220019393 | 220017662 | 1.69 | 57.7 | Curative (C) | 2014-07-07 | 2014-07-18 | Rituximab | 2 | N | 220028396 | RITUXIMAB |
| 220019394 | 220014059 | null | 93.2 | Palliative (P) | 2016-12-26 | 2017-02-13 | AML 18 TRIAL | Y | N | 220028402 | AML18 TRIAL |
| 220019395 | 220007368 | null | null | Curative (C) | 2015-07-19 | 2015-09-08 | Dasatinib | N | null | 220028452 | DASATINIB |
| 220019396 | 220019691 | null | null | Disease modification (D) | 2015-08-05 | 2015-08-05 | AML 18 TRIAL | Y | N | 220028471 | AML18 TRIAL |
| 220019397 | 220007377 | 1.77 | 81.2 | Curative (C) | 2018-10-03 | 2018-10-03 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220028484 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019398 | 220007379 | 1.48 | 80.9 | Disease modification (D) | null | 2013-09-25 | AML 18 Pilot Trial | 02 | N | 220028490 | PILOT TRIAL |
| 220019399 | 220007382 | 1.83 | 0 | Curative (C) | 2016-06-20 | 2017-01-24 | Dasatinib | N | N | 220028491 | DASATINIB |
| 220019400 | 220007384 | 1.86 | 76.5 | Adjuvant (A) | 2014-12-21 | 2015-01-22 | AML 18 TRIAL | N | N | 220028504 | AML18 TRIAL |
| 220019401 | 220007390 | 1.78 | 90.1 | Disease modification (D) | 2016-04-26 | 2016-04-26 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220028517 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019402 | 220007391 | 1.86 | 84 | Curative (C) | 2015-08-06 | 2015-12-25 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | null | 220028520 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019403 | 220007394 | 1.58 | null | Curative (C) | 2018-01-06 | 2018-08-18 | Dasatinib | N | N | 220028533 | DASATINIB |
| 220019404 | 220007397 | 1.76 | 83 | Curative (C) | 2017-04-21 | 2017-06-10 | AML18 PILOT TRIAL | 01 | N | 220028542 | PILOT TRIAL |
| 220019405 | 220007402 | 1.54 | 0 | Curative (C) | 2015-08-24 | 2015-08-24 | Dasatinib | N | N | 220028566 | DASATINIB |
| 220019406 | 220007410 | 1.73 | 66.6 | Curative (C) | 2014-11-28 | 2014-11-28 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220028602 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019407 | 220007418 | null | 83 | Neo-adjuvant (N) | null | 2014-05-16 | AML18 PILOT TRIAL | 01 | null | 220028662 | PILOT TRIAL |
| 220019408 | 220007421 | 1.72 | 40.3 | Curative (C) | 2016-02-08 | 2016-02-08 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220028665 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019409 | 220007422 | 0 | 27.5 | Disease modification (D) | 2018-02-10 | 2018-02-10 | Rituximab | N | N | 220028667 | RITUXIMAB |
| 220019410 | 220007423 | 1.66 | null | Curative (C) | 2016-07-23 | 2016-07-23 | Dasatinib | N | N | 220028681 | DASATINIB |
| 220019411 | 220007424 | 1.8 | 99.7 | Palliative (P) | 2017-10-04 | 2017-10-05 | Dasatinib | N | null | 220028683 | DASATINIB |
| 220019412 | 220007425 | 1.63 | 58.6 | Curative (C) | 2014-05-11 | 2014-05-29 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220028684 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019413 | 220014091 | 1.79 | 72.2 | Disease modification (D) | 2016-07-18 | 2016-07-31 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | null | 220028687 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019414 | 220007430 | 1.8 | 83.6 | null | 2014-10-14 | 2014-11-03 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220028709 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019415 | 220007433 | 1.61 | null | Disease modification (D) | 2015-10-17 | 2015-11-03 | Rituximab | N | N | 220028710 | RITUXIMAB |
| 220019416 | 220014095 | 1.7 | 72.2 | Curative (C) | 2017-01-01 | 2017-01-28 | Dasatinib | N | null | 220028725 | DASATINIB |
| 220019417 | 220021515 | 1.55 | null | Curative (C) | 2017-08-08 | 2018-02-27 | Dasatinib | 99 | N | 220028735 | DASATINIB |
| 220019418 | 220007442 | 1.6 | 77.7 | Curative (C) | 2017-03-30 | 2017-07-14 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220028763 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019419 | 220021516 | null | null | Curative (C) | 2014-07-16 | 2014-08-17 | AML 18 TRIAL | 1 | N | 220028778 | AML18 TRIAL |
| 220019420 | 220007447 | 1.58 | 75 | Curative (C) | 2014-10-06 | 2014-10-06 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220028784 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019421 | 220007450 | 1.8 | 79 | Curative (C) | 2018-02-01 | 2018-03-19 | Dasatinib | 02 | N | 220028792 | DASATINIB |
| 220019422 | 220007452 | 1.6 | 0 | Disease modification (D) | 2013-01-03 | 2013-05-25 | Dasatinib | null | null | 220028801 | DASATINIB |
| 220019423 | 220007458 | null | 61 | Disease modification (D) | 2018-03-30 | 2018-03-30 | AML18 PILOT TRIAL | N | N | 220028807 | PILOT TRIAL |
| 220019424 | 220014106 | 1.88 | 90.1 | null | 2018-02-12 | 2018-02-16 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220028812 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019425 | 220007464 | 1.7 | null | Curative (C) | 2014-06-01 | 2014-06-02 | Rituximab | 2 | N | 220028832 | RITUXIMAB |
| 220019426 | 220007472 | null | 89.1 | Curative (C) | 2015-05-21 | 2015-05-25 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220028868 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019427 | 220007478 | 1.58 | null | Curative (C) | 2016-06-17 | 2016-06-17 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220028892 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |